Compass Therapeutics to Participate in Upcoming December Investor Events
Provided By GlobeNewswire
Last update: Nov 25, 2025
BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in the following investor events during the month of December.
Read more at globenewswire.com
